WednesdayFeb 03, 2021 2:21 pm

PacRoots Cannabis Corp. (CSE: PACR) (OTCQB: PACRF) Set to Thrive as Peers Face Pain of Excess Supply

PacRoots Cannabis recently updated investors following its first successful hemp harvest, which resulted in 105,000 lbs. of biomass of higher-than-expected quality Canadian cannabis market is currently awash in oversupply, with some estimates placing inventory stockpile at close to 3 years’ worth of demand Industry participants have pointed at low-quality grades as prime cause for the oversupply PacRoots has taken strides to improve quality of its plants, most notably through collaboration with Phenome One Corp PacRoots processes, sells entirety of recent harvest to the Speakeasy Cannabis Club PacRoots Cannabis (CSE: PACR) (OTCQB: PACRF), an up-and-coming cannabis company based out of Canada,…

Continue Reading

WednesdayFeb 03, 2021 1:54 pm

RYAH Group Inc. Partners with THC Lab to Launch Dose-Measuring Inhaler and Data Analytics Platform in Italy, Netherlands

Agreement between RYAH, THC Lab outlines parameters for launch of RYAH’s IoT dose-measuring Smart-Inhaler Aim of agreement is to reach hundreds of pharmacies, establish RYAH as the market standard for vaporizing The two companies also planning to work together on controlled research, bioavailability testing projects RYAH Group, a leading digital health care analytics and technology company, has entered into a research-and-distribution arrangement THC Lab, which specializes in providing products and services to compounding pharmacies in Italy and other European countries in the specific field of medical cannabis (https://cnw.fm/9S8To). The agreement outlines the parameters for the launch of RYAH’s IoT dose-measuring…

Continue Reading

TuesdayFeb 02, 2021 3:35 pm

XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Is ‘One to Watch’

XPhyto Therapeutics Corp. is a bioscience accelerator focused on next-generation drug delivery, diagnostic and new active pharmaceutical ingredient investment opportunities The company has research and development operations in North America and Europe and an operational focus in Germany XPhyto’s operations are concentrated into three core divisions: infectious disease diagnostics, clinical development of transdermal and sublingual drug formulations, and psychedelic medicine The company’s lead diagnostic product is an accurate, rapid and highly portable PCR diagnostic test system being evaluated in Europe for the detection of COVID-19 XPhyto’s German subsidiary, Vektor Pharma TF GmbH, is advancing four therapeutic programs targeting neurological indications;…

Continue Reading

CanadianCannabisWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 905.674.5977